MEGADOSE METHYLPREDNISOLONE FOR PROMYELOCYTIC LEUKEMIA

ISSN： 1521-0669

Source： Pediatric Hematology and Oncology, Vol.17, Iss.8, 2000-12, pp. : 723-723

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

MEGADOSE METHYLPREDNISOLONE FOR EVANS SYNDROME

By Özsoylu Şinasi

Pediatric Hematology and Oncology, Vol. 17, Iss. 8, 2000-12 ,pp. : 725-726

Informa Healthcare

Access to resources Recommend Favorite

MEGADOSE METHYLPREDNISOLONE FOR KASABACH-MERRITT SYNDROME

By Ozsoylu Sinasi

Pediatric Hematology and Oncology, Vol. 16, Iss. 4, 1999-07 ,pp. : 373-374

Informa Healthcare

Access to resources Recommend Favorite

TREATMENT OF KASABACH–MERRITT SYNDROME BY MEGADOSE METHYLPREDNISOLONE

By Özsoylu Şinasi

Pediatric Hematology and Oncology, Vol. 19, Iss. 5, 2002-07 ,pp. : 373-374

Informa Healthcare

Access to resources Recommend Favorite

COMMENTS ON: Megadose Methylprednisolone for the Treatment of Patients with Evans Syndrome

By Ruggiero Antonio

Pediatric Hematology and Oncology, Vol. 21, Iss. 8, 2004-12 ,pp. : 741-741

Informa Healthcare

Access to resources Recommend Favorite

THE EFFECTS OF MEGADOSE METHYLPREDNISOLONE THERAPY ON THE IMMUNE SYSTEM IN CHILDHOOD IMMUNE THROMBOCYTOPENIA

By Yetgin Sevgi Yenicesu Idil Ersoy Figen

Pediatric Hematology and Oncology, Vol. 22, Iss. 5, 2005-07 ,pp. : 401-407

Informa Healthcare

Access to resources Recommend Favorite